Clinical Trial Experience
Over the years, we have built strong partnerships with pharmaceutical companies by successfully conducting clinical trials across various therapeutic areas. The table below highlights selected studies, showcasing our capabilities and experience in clinical research.
|
Sponsor |
Study title |
Phase |
|
Alpex Pharma SA, Switzerland |
A randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy and safety of oral BT-11 in moderate to severe Crohn's disease |
Multicenter/II |
|
OCTAPHARMA Pharmazeutika Produktionsges.m.b.H., Austria |
An open-label, prospective, single-arm, multicenter study to evaluate the safety and pharmacokinetics of a single intravenous dose of human plasma-derived C1-esterase inhibitor (C1-INH) concentrate in patients with congenital C1-INH deficiency and hereditary angioedema |
Multicenter/III |
|
OCTAPHARMA Pharmazeutika Produktionsges.m.b.H., Austria |
Clinical study to evaluate the efficacy and safety of Wilate during prophylaxis in previously treated patients with von Willebrand disease |
Multicenter/III |
|
Biopharma, Ukraine |
An open multicenter study to evaluate the efficacy, safety and some pharmacokinetic parameters of the drug Bioven, 10% solution for infusions, manufactured by Biopharma Plasma LLC, in patients with primary immunodeficiencies |
Multicenter/III |
|
Bayer Pharma AG, Germany |
Evaluation of Rivaroxaban versus placebo in reducing the risk of venous thromboembolism after hospital discharge in patients with somatic pathology (MARINER) |
Multicenter/IV |
|
Cilag AG, Switzerland |
A multicenter, randomized, double-blind, placebo-controlled study of Golimumab, an anti-TNF-α monoclonal antibody, administered intravenously, in patients with active psoriatic arthritis |
Multicenter/III |
|
Pharmland, Belarus |
Comparative randomized open controlled clinical trial of the efficacy and safety of the drug Sevoflurane, inhalation liquid, manufactured by PHARMLAND, Republic of Belarus, used for inhalation anesthesia,versus the drug Sevoflurane, inhalation liquid, manufactured by aesica queenborough LTD, UK |
National/Pre-registration limited |
|
Celgene International Sarl, Switzerland |
A multicenter, randomized, double-blind, placebo-controlled, three-arm parallel-group study to determine the efficacy and safety of lenalidomide (Revlemid®) in combination with Melphalan and Prednisolone versus placebo in combination with Melphalan and Prednisolone in subjects over 65 years of age with newly diagnosed multiple myeloma |
Multicenter/III |
|
Academpharm, Belarus |
|
National/IV |
|
CSL Limited Bioplasma Division, Australia |
An open-label, multicenter, phase III study to evaluate the efficacy, pharmacokinetics, and safety of Biostat® in children with hemophilia A |
Multicenter/III |
|
CSL Limited Bioplasma Division, Australia |
An open-label, multicenter, phase III study to evaluate the efficacy, pharmacokinetics, and safety of Biostat® in children with Willebrand disease |
Multicenter/III |